N@N

Advaxis Announces 2011 Annual Meeting of Stockholders

^{Published on 2011-08-30 06:28:13 - Market Wire}
 

PRINCETON, N.J.--([ BUSINESS WIRE ])--[ Advaxis, Inc ]., (OTCBB: ADXS), a leader in developing the next generation of immunotherapies for cancer and infectious diseases, announces that its Annual Meeting of Stockholders will be held on Tuesday, September 27, 2011, at 10:00 a.m. Eastern Daylight Time at the D&R Greenway Land Trust, Johnson Education Center, One Preservation Place, Princeton, NJ 08540.

The meeting Agenda includes voting on proposals fully described in the 2011 Proxy Statement filed on August 29, 2011and to transact any other business as may properly come before the Annual Meeting. Following the formal portion of the meeting, Advaxis Chairman/CEO Thomas A. Moore will provide an update on Company initiatives including the status of the Advaxis clinical trial program and the Companya™s future plans. A copy of Mr. Moorea™s presentation will be available on the Companya™s website ([ www.advaxis.com ]) following the meeting.

About Advaxis, Inc.

Advaxis is a biotechnology company developing the next generation of immunotherapies for cancer and infectious diseases. Our novel platform technology is designed to generate a comprehensive immune response by serving as its own adjuvant, directing antigen presentation, increasing tumor infiltrating killer T-cells, and decreasing Tregs/MDSCs in the tumor. Today, the Company has over fifteen (15) distinct constructs in various stages of development, directly developed by the Company and through strategic collaborations with recognized centers of excellence such as: the [ National Cancer Institute ], [ Cancer Research a" UK ], the [ Wistar Institute ], the [ University of Pennsylvania ], and the [ Department of Homeland Security ] among others. Please visit: [ advaxis.com ] | [ facebook ] | [ twitter ] | [ LinkedIn ]

Forward-Looking Statements

Certain statements contained in this press release are forward-looking statements that involve risks and uncertainties. The statements contained herein that are not purely historical are forward looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended.Forward-looking statements deal with the Companya™s current plans, intentions, beliefs and expectations and statements of future economic performance.Forward-looking statements involve known and unknown risks and uncertainties that may cause the Company's actual results in future periods to differ materially from what is currently anticipated. Factors that could cause or contribute to such differences include those discussed from time to time in reports filed by the Company with the Securities and Exchange Commission. The Company cannot guarantee its future results, levels of activity, performance or achievements.